Welcome to our dedicated page for CareTrust REIT SEC filings (Ticker: CTRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CareTrust REIT, Inc. filings document the financial reporting, governance and capital-structure disclosures of a healthcare real estate investment trust. Form 8-K reports cover operating results, Regulation FD supplemental information, investor presentations, material definitive agreements and stockholder voting outcomes.
Proxy materials describe board elections, executive compensation, auditor ratification and related governance matters. Material agreement filings address the company and CTR Partnership, L.P., including equity distribution arrangements for common stock and operating partnership amendments that establish LTIP Units. These records also document REIT operating metrics, partnership-unit structure and financing tools used alongside the company’s skilled nursing, seniors housing and other healthcare property portfolio.
Wellington Management Group LLP, together with Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP, reports beneficial ownership of 9,700,334 shares of CareTrust REIT, Inc. common stock, representing 4.11% of the class as of June 30, 2026.
The group reports no sole voting or dispositive power, with shared voting power over 7,617,055 shares and shared dispositive power over 9,700,334 shares. The shares are owned of record by clients of various Wellington investment advisers, and no individual client is known to hold more than five percent of the class. The filing indicates ownership of five percent or less of CareTrust REIT’s common stock.
Cohen & Steers, Inc. and affiliated investment advisers report beneficial ownership of 11,036,150 shares of CareTrust REIT, Inc. common stock, representing 4.67% of the class. They hold 7,655,600 shares with sole voting power and 11,036,150 shares with sole dispositive power, with no shared voting or dispositive power.
The shares are held by Cohen & Steers Capital Management, Inc., Cohen & Steers UK Ltd, Cohen & Steers Asia Ltd and Cohen & Steers Ireland Ltd for the benefit of their respective account holders, who are entitled to dividends and sale proceeds. Cohen & Steers, Inc. owns 100% of these subsidiaries.
CareTrust REIT, Inc. reported significantly higher results for the quarter ended June 30, 2026 and updated its 2026 outlook. Q2 net income was $89.0 million, or $0.38 per diluted share, up $0.03 or 9% year over year. Total revenues rose 43% to $161.3 million. Normalized FFO was $119.7 million and Normalized FAD $118.5 million, both $0.51 per diluted share, 19% above the prior-year quarter, while contractual rent and interest were collected at 100%.
The company closed $899.6 million of investment activity in Q2 at an 8.9% blended stabilized yield and reports $307.9 million of additional post-quarter investments and a $540 million pipeline. Net Debt to Annualized Normalized Run Rate EBITDA was 1.01x, with $605 million available on its $1.2 billion revolver, $90 million of cash and no scheduled debt maturities before 2028. A quarterly dividend of $0.39 per share represented approximately 76% of Normalized FAD. For 2026, CareTrust now projects net income of $1.53–$1.56, Normalized FFO of $2.03–$2.06 and Normalized FAD of $2.01–$2.04 per diluted share; management noted the new Normalized FFO and FAD midpoints are 16.2% and 15.1% above 2025 results.
CareTrust REIT, Inc. focuses on acquiring, financing, developing and owning healthcare real estate, primarily skilled nursing and senior housing, across 33 U.S. states and the U.K. As of June 30, 2026 it owned 426 properties with 39,667 beds and units, plus other real estate-related investments and financing receivables totaling over $1.7 billion in carrying value.
For the quarter ended June 30, 2026, total revenues were $161,348 thousand, with net income attributable to CareTrust of $88,996 thousand, or $0.38 per diluted share. Total assets were $5,929,251 thousand, including real estate investments, net, of $4,062,841 thousand. Operating cash flow for the first half of 2026 was $225,114 thousand, while heavy investment activity drove $990,698 thousand of cash used in investing.
During the first half of 2026, CareTrust acquired $423,576 thousand of real estate across 20 properties and originated $259,599 thousand of new mortgage and mezzanine loans, plus $467,129 thousand of new financing receivables. Debt principal outstanding reached $1,210,000 thousand (revolver, term loan and notes). The company raised equity through its at-the-market program and forward equity offerings and had future minimum contractual rental income of $6,009,182 thousand under operating leases.
CareTrust REIT, Inc. entered into an underwriting and forward sale structure for its common stock with Wells Fargo and J.P. Morgan affiliates. The arrangements cover 12,500,000 firm shares and an additional 1,875,000 optional shares of common stock sold at $40.225 per share to the underwriters.
On May 20, 2026, the underwriters exercised the full option, and CareTrust entered additional forward sale agreements for the optional shares. On May 21, 2026, the forward sellers borrowed and sold 1,875,000 optional shares into the offering. Related forward sale agreements and a Maryland law opinion were filed as exhibits.
CareTrust REIT, Inc. entered into an underwriting and forward sale structure for a public equity offering of 12,500,000 firm shares of common stock, plus up to 1,875,000 optional shares, at a price to the underwriters of $40.225 per share. The company entered separate forward sale agreements with Wells Fargo Bank, National Association and JPMorgan Chase Bank, National Association, under which forward purchasers borrowed and sold 12,500,000 shares on May 20, 2026. CareTrust currently expects to settle these agreements by physically delivering shares for cash on one or more dates no later than May 20, 2027, but it may alternatively elect cash or net share settlement under specified conditions.
CareTrust REIT, Inc. is offering 12,500,000 shares of common stock through forward sale agreements that anticipate physical settlement within approximately one year. The underwriters agreed to purchase at $40.225 per share, implying approximately $502.8 million of proceeds to the company before expenses assuming full physical settlement.
The forward purchasers will initially borrow and sell the shares to the underwriters; CareTrust will not receive proceeds until physical settlement (subject to daily forward price adjustments and settlement elections including cash or net‑share settlement). The prospectus supplement discloses ownership transfer limits (9.8% thresholds), an underwriter option for 1,875,000 additional shares, and shares outstanding of 236,240,235 as of May 15, 2026.
CareTrust REIT is registering an offering of 10,000,000 shares of its common stock. The prospectus supplement describes a forward sale structure under which forward purchasers are expected to borrow and sell an aggregate of 10,000,000 shares (11,500,000 if the underwriters’ option is exercised).
The company will not initially receive proceeds from the borrowed shares; it expects, subject to adjustment and settlement mechanics, to receive net proceeds upon physical settlement of the forward sale agreements, which it anticipates will occur within approximately one year. The supplement discloses ownership limits (9.8%), a 30-day underwriter option for 1,500,000 additional shares and that shares outstanding were 236,240,235 as of May 15, 2026.
CareTrust REIT, Inc. ownership disclosure: Cohen & Steers and certain affiliates report beneficial ownership of 12,189,752 shares of Common Stock, representing 5.46% of the class as reported in this amendment.
The filing breaks ownership among related entities (Cohen & Steers, Cohen & Steers Capital Management, Cohen & Steers UK, Asia and Ireland) and states these shares are held for the benefit of their respective account holders.
CareTrust REIT, Inc. reported strong first-quarter 2026 growth and raised its full-year 2026 guidance. Net income attributable to CareTrust rose to $80.2 million, or $0.36 per diluted share, while Normalized FFO reached $107.4 million, or $0.48 per share, up 14% from a year earlier. Normalized FAD was $107.6 million, or $0.48 per share, up 12%. The company closed $245.1 million of Q1 investment activity at an 8.8% blended stabilized yield and has since closed $864.1 million more at an 8.9% yield. Net Debt to Annualized Normalized Run Rate EBITDA was just 0.6x, and CareTrust increased its quarterly dividend to $0.39 per share, a 16.4% year-over-year increase with an approximately 81% Normalized FAD payout ratio. Updated 2026 guidance now calls for net income of $1.49–$1.53 per share and Normalized FFO of $2.00–$2.04 per share, with midpoint growth of 14.8% for Normalized FFO and 13.6% for Normalized FAD versus 2025.